河南省和河北省藥品不良反應(yīng)報(bào)告單位調(diào)查研究
[Abstract]:Objective: to understand the status quo of (ADR) reporting units of adverse drug reactions in Henan and Hebei provinces, and to provide basis for the improvement of ADR monitoring. Methods: the general situation of ADR monitoring at home and abroad was investigated by consulting the literature. Cluster sampling was conducted with ADR reporting units (drug manufacturing enterprises, drug trading enterprises, medical institutions) in Henan Province and Hebei Province, and questionnaires were distributed. The method of descriptive statistical analysis is used to deal with and analyze the survey results. Results: 186 valid questionnaires were collected. In Henan Province and Hebei Province, 58 and 62 ADR monitoring departments were established by ADR reporting units interviewed in Henan Province and Hebei Province respectively, and all of them were specially staffed to take charge of ADR work. Most of the enterprises belong to the quality management department, most of the medical institutions belong to the pharmacy department; most of them are equipped with basic office equipment such as computer, printer, telephone, etc. There were 24 and 2 special budgets for ADR monitoring, 95.7% and 96.8% of them had communication with local ADR monitoring center, but the information feedback was not satisfactory. 86.7% and 98.9% of the staff were trained respectively. It was found that 96.7% and 98.9% of the ADR would be reported immediately, 92.3% and 97.8% of the reported ADR would be backed up and recorded, respectively. The main form of the report was in the form of network report, and the average score of Henan Province was higher than that of Hebei Province in terms of job satisfaction evaluation. Conclusion: in view of the investigation results, it is suggested that the work of ADR monitoring should be promoted by clarifying the duties of ADR monitoring, optimizing the working conditions, ensuring the work expenses and strengthening the work feedback and so on.
【作者單位】: 西安交通大學(xué)醫(yī)學(xué)部藥學(xué)院;
【基金】:國(guó)家社會(huì)科學(xué)基金資助項(xiàng)目(No.13BGL132)
【分類號(hào)】:R951
【參考文獻(xiàn)】
相關(guān)期刊論文 前1條
1 劉花;馮變玲;楊世民;張智;;我國(guó)省級(jí)藥品不良反應(yīng)監(jiān)測(cè)機(jī)構(gòu)發(fā)展現(xiàn)狀的調(diào)查分析[J];中國(guó)藥房;2014年12期
【共引文獻(xiàn)】
相關(guān)期刊論文 前3條
1 劉花;馮變玲;楊世民;;藥品不良反應(yīng)研究現(xiàn)狀與展望[J];醫(yī)藥導(dǎo)報(bào);2013年10期
2 郭佳棟;張雪梅;白軍鋒;張智;馮變玲;;陜西省藥品不良反應(yīng)報(bào)告主體工作現(xiàn)狀的實(shí)證研究[J];藥物流行病學(xué)雜志;2015年05期
3 張雪梅;馮變玲;楊世民;郭佳棟;肖勛霞;;江蘇省和廣東省藥品不良反應(yīng)報(bào)告單位調(diào)查研究[J];中國(guó)藥房;2015年21期
【二級(jí)參考文獻(xiàn)】
相關(guān)期刊論文 前1條
1 謝金洲;周勇;田月潔;黃傳海;陳易新;;我國(guó)省級(jí)藥品不良反應(yīng)監(jiān)測(cè)機(jī)構(gòu)模式研究[J];中國(guó)藥物警戒;2009年01期
【相似文獻(xiàn)】
相關(guān)期刊論文 前8條
1 楊茂瑜;郎中凱;;EXCEL在公共用具檢測(cè)報(bào)告中的應(yīng)用[J];中國(guó)衛(wèi)生檢驗(yàn)雜志;2013年13期
2 曹玲生;劉大衛(wèi);郭飚;曹雷;殷大鵬;武文娣;王華慶;梁曉峰;;中國(guó)兒童預(yù)防接種信息管理系統(tǒng)建設(shè)基線調(diào)查[J];中國(guó)疫苗和免疫;2008年05期
3 楊藝;付益仁;;寧夏2004~2007年突發(fā)公共衛(wèi)生事件分析[J];中國(guó)公共衛(wèi)生;2008年12期
4 楊太華;邰新蓉;薛峰;;新疆結(jié)核病網(wǎng)絡(luò)直報(bào)與病人追蹤情況分析研究[J];地方病通報(bào);2007年06期
5 趙連;張莉梅;王世平;王宏麗;趙朋;;大連市腫瘤報(bào)告管理信息系統(tǒng)開(kāi)發(fā)與應(yīng)用[J];中國(guó)公共衛(wèi)生;2008年02期
6 王學(xué)娟,劉義;1起誤食硝酸鹽引起食物中毒的調(diào)查分析[J];職業(yè)與健康;2000年09期
7 李龍威;袁平;曹玲生;鄭景山;漆琪;張峰;梁雪峰;曹雷;張國(guó)民;殷大鵬;朱徐;王華慶;梁曉峰;;地震災(zāi)區(qū)兒童預(yù)防接種信息化建設(shè)項(xiàng)目地區(qū)預(yù)防接種單位客戶端數(shù)據(jù)準(zhǔn)確性分析[J];中國(guó)疫苗和免疫;2012年04期
8 ;[J];;年期
相關(guān)重要報(bào)紙文章 前3條
1 王加林 姚群 楊曉霞;監(jiān)督就要?jiǎng)诱娓馵N];中國(guó)紀(jì)檢監(jiān)察報(bào);2005年
2 龐清濤;“審查”和“審議”不能混用[N];人民代表報(bào);2006年
3 張黎明;省級(jí)ADR監(jiān)測(cè)工作思路初探[N];中國(guó)醫(yī)藥報(bào);2006年
,本文編號(hào):2283336
本文鏈接:http://sikaile.net/yixuelunwen/yiyaoxuelunwen/2283336.html